Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$3.94 - $5.44 $43,848 - $60,541
-11,129 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$19.18 - $27.88 $213,454 - $310,276
11,129 New
11,129 $303,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $222M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.